XML 85 R54.htm IDEA: XBRL DOCUMENT v3.25.1
Statutory Reserves And Restricted Net Assets (Tables)
12 Months Ended
Dec. 31, 2024
Condensed Financial Information Disclosure [Abstract]  
Statement Of Financial Position
Balance Sheet
 
 
  
As of December 31,
2023
 
  
As of December 31,
2024
 
 
  
RMB
 
  
RMB
 
ASSETS
     
Cash and cash equivalents
     15,466        99,459  
Amounts due from the Group’s entities
     174,801        185,892  
Investments in subsidiaries, VIE and VIE’s subsidiaries
     60,013        —   
Other
non-current
assets
     16,253        548  
  
 
 
    
 
 
 
Total assets
     266,533        285,899  
  
 
 
    
 
 
 
LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ DEFICIT
     
Amounts due to the Group’s entities
     35,613        35,613  
Equity loss in subsidiaries, VIE and VIE’s subsidiaries
     —         12,021  
Acquisition consideration payable
     8,983        8,983  
Other payable and accrued liabilities
     3,857        2,052  
Derivative liabilities
     100,279        —   
  
 
 
    
 
 
 
Total liabilities
     148,732        58,669  
  
 
 
    
 
 
 
 

 
  
As of December 31,
2023
 
 
As of December 31,
2024
 
 
  
RMB
 
 
RMB
 
Mezzanine equity
  
 
Series A convertible redeemable preferred shares (US$0.0001 par value, 15,040,570 and nil shares authorized, issued and outstanding as of December 31, 2023 and 2024, respectively)
     408,139       —   
Series B convertible redeemable preferred shares (US$0.0001 par value, 7,085,330 and nil shares authorized, issued and outstanding as of December 31, 2023 and 2024, respectively)
     199,518       —   
Series C convertible redeemable preferred shares (US$0.0001 par value, 23,786,590 and nil shares and authorized, issued and outstanding as of December 31, 2023 and 2024, respectively)
     493,788       —   
Series D convertible redeemable preferred shares (US$0.0001 par value, 37,152,161 and nil shares authorized, issued and outstanding as of December 31, 2023 and 2024, respectively)
     1,059,434       —   
Series E convertible redeemable preferred shares (US$0.0001 par value, 26,417,318 and nil shares authorized, issued and outstanding as of December 31, 2023 and 2024, respectively)
     1,402,802       —   
  
 
 
   
 
 
 
Total mezzanine equity
     3,563,681       —   
  
 
 
   
 
 
 
Shareholders’ (deficit)/equity
      
Ordinary shares (US$0.0001 par value
 per share;
390,518,031 shares authorized
 as of December 31, 2023;
48,253,425
shares
issued and outstanding as of December 31, 2023
; None authorized, issued and outstanding as of December 31,
2024)
     33       —   
Class A Ordinary shares (US$0.0001 par value per share; none authorized, issued and outstanding as of December 31, 2023; 483,068,176 Class A ordinary shares authorized, 163,294,773 Class A ordinary shares issued and outstanding as of December 31, 2024)
     —        118  
Class B Ordinary shares (US$0.0001 par value per share; none authorized, issued and outstanding as of December 31, 2023; 16,931,824 Class B ordinary shares authorized, issued and outstanding as of December 31, 2024)
     —        11  
Additional
paid-in
capital
     16,671       3,489,553  
Accumulated other comprehensive income
     23,775       25,096  
Accumulated deficit
     (3,486,359     (3,287,548 )
 
  
 
 
   
 
 
 
Total shareholders’ (deficit)/equity
     (3,445,880     227,230  
  
 
 
   
 
 
 
Total liabilities, mezzanine equity and shareholders’ (deficit)/equity
     266,533       285,899  
  
 
 
   
 
 
 
Statement Of Income And Comprehensive Income
Statements of Comprehensive Loss


 
  
Year Ended
December 31,

2022
 
  
Year Ended
December 31,

2023
 
  
Year Ended
December 31,

2024
 
 
  
RMB
 
  
RMB
 
  
RMB
 
General and administrative
     (9,050      (27,856      (15,730 )
Equity in loss of the Group’s entities
     (575,930      (295,718      (106,358 )
  
 
 
    
 
 
    
 
 
 
Loss from operation
     (584,980      (323,574      (122,088 )
  
 
 
    
 
 
    
 
 
 
Interest and investment income
     2,454        756        408  
Interest expense
     (59      (56      (23
Impairment of available-for-sale debt securities
     —         —         (4,428
Change in fair value of derivative liabilities
     (32,190      102,419        34,378  
  
 
 
    
 
 
    
 
 
 
Loss before income tax expense
     (614,775      (220,455      (91,753 )
  
 
 
    
 
 
    
 
 
 
Net loss
     (614,775      (220,455      (91,753 )
  
 
 
    
 
 
    
 
 
 
Net accretion on convertible redeemable preferred shares to redemption value
     (396,716      (9,452      (290,543
Deemed contribution to ordinary shareholders due to modifications and extinguishment on convertible redeemable preferred shares
     —         —         672,170  
Deemed dividend to preferred shareholders due to modifications
     —         —         (5,940
  
 
 
    
 
 
    
 
 
 
Net (loss)/income attributable to ordinary shareholders
     (1,011,491      (229,907 )      283,934  
  
 
 
    
 
 
    
 
 
 
Statement Of Cash Flows
Statement of Cash Flows
 
 
  
Year Ended
December 31,
2022
 
  
Year Ended
December 31,
2023
 
  
Year Ended
December 31,
2024
 
 
  
RMB
 
  
RMB
 
  
RMB
 
Net cash used in operating activities
     (6,211      (29,486      (20,519 )
 
Net cash used in investing activities
     (150,456      (172,856      (44,013 )
Net cash (used in)/ provided by in financing activities
     (2,425      (3,896      151,029  
Effect of exchange rate changes on cash and cash equivalents
     22,430        8,146        (2,504 )
  
 
 
    
 
 
    
 
 
 
Net (decrease)/increase in cash and cash equivalents
     (136,662      (198,092      83,993  
Cash and cash equivalents at beginning of the year
     350,220        213,558        15,466  
  
 
 
    
 
 
    
 
 
 
Cash and cash equivalents at end of the year
     213,558        15,466        99,459